EVONETIX LTD (‘Evonetix’), the synthetic biology company bringing semiconductor technology to DNA synthesis, has received The Award for Innovation at this year’s Cambridge Independent Science and Technology Awards, in recognition of the Company’s novel gene synthesis technology and its potential to facilitate the rapidly growing field of synthetic biology.
Evonetix’s novel semiconductor-based synthesis chip uses precise temperature control to manage the DNA synthesis cycle at thousands of individually addressable sites across the surface of the chip. The patented method for DNA synthesis enables highly parallel synthesis and the ability to remove errors during the assembly of gene sequences.
The Cambridge Independent Science and Technology Awards recognise outstanding life science and biotechnology companies in Cambridge. The ceremony took place at Hinxton Hall on the Wellcome Genome Campus and was attended by leaders of businesses, organisations and research institutes across the Cambridge region on 11th May, 2022.
Evonetix was previously named Life Science Company of the Year at the 2020 Cambridge Independent Science and Technology Awards.
Matthew Hayes, Chief Technology Officer at Evonetix, commented: “It is an honour to have been recognised for a second year by this prestigious award. Building on our successes from 2020, we have achieved many important milestones for the Company as we progress our product development. We’re looking forward to continuing this trajectory to bring our desktop printer to thousands of labs and facilitate the growing field of synthetic biology.”
For more information about Evonetix, please visit: www.evonetix.com.